Rikke Egelund

1.3k citations
10 papers · 1.2k indexed · 1 hit paper · h-index 10

Rikke Egelund

10 papers receiving 1.1k citations

Hit Papers

The plasminogen activation system in tumor growth, invasi...7992000202620082017250500750

Peers

Rikke Egelund
Comparison fields: 5 of 81
  • Cancer Research 707
  • Immunology and Allergy 218
  • Hematology 380
  • Genetics 98
  • Oncology 236
Replace Lothar Goretzki with:
Lothar Goretzki Germany
Gregg Hastings United States
Tammy L. Moser United States
Ilka Warshawsky United States
Harvey W. Smith Canada
Elisabetta Rovida Italy
Keena S. Thomas United States
Karen A. Olson United States
Dominique Grall France
Kalyani Penta United States
Rikke Egelund relative to Lothar Goretzki Germany Lothar Goretzki's profile →
Citations per field
00.5×2.6×
Lothar Goretzki · 1×
Citations per year

Countries citing papers authored by Rikke Egelund

Since Specialization
Citations

This map shows the geographic impact of Rikke Egelund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rikke Egelund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rikke Egelund more than expected).

Fields of papers citing papers by Rikke Egelund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rikke Egelund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rikke Egelund. The network helps show where Rikke Egelund may publish in the future.

Co-authorship network

The 21 scholars most cited alongside Rikke Egelund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rikke Egelund Line = papers co-authored together Rikke Egelund links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 200870
2 200629
3 200158
4 200148
5
The plasminogen activation system in tumor growth, invasion, and metastasisbreakdown →
2000799
6 200023
7 199913
8 199923
9 199856
10 199739

About Rikke Egelund

Rikke Egelund is a scholar working on Cancer Research, Hematology and Genetics, having authored 10 papers that have together received 1.2k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (9 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), S100 Proteins and Annexins (2 papers), Peptidase Inhibition and Analysis (2 papers), Antioxidant Activity and Oxidative Stress (1 paper), Cellular transport and secretion (1 paper) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Cancer Research (707 citations), Immunology and Allergy (218 citations) and Hematology (380 citations). Rikke Egelund has collaborated with scholars based in Denmark, United Kingdom and United States. Frequent co-authors include P.A. Andreasen, Heidi Huus Petersen, Peter A. Andreasen, Kees W. Rodenburg, Torben E. Petersen, John G. Flanagan, Miriam Osterfield, Lauren M. Young, Katrine E. Pedersen and Anni Christensen. Their work appears in journals such as Journal of Biological Chemistry, Development and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026